, ,

Osphos 51 Mg/Ml Solution For Injection

$45.00

Description

Osphos 51 mg/mL Solution for Injection is a bisphosphonate-base medication used in veterinary medicine to treat clinical signs of navicular syndrome in horses. Navicular syndrome is a common condition affecting the front feet of horses, characterized by pain and inflammation in the navicular bone and surrounding tissues, leading to lameness and decreased performance. Osphos helps by slowing down the bone resorption process, reducing pain, and improving mobility in affected horses.

Active Ingredient:

  • Clodronate Disodium (51 mg/mL):
    Clodronate disodium is a bisphosphonate, a type of drug that helps prevent the loss of bone mass. Bisphosphonates work by inhibiting osteoclasts—cells that break down bone—thereby slowing the process of bone resorption. This mechanism helps alleviate pain in horses suffering from navicular syndrome by stabilizing bone remodeling and preventing further damage to the navicular bone.

How It Works:

Osphos targets the bone tissue and reduces the activity of osteoclasts. Osteoclasts are responsible for breaking down bone, which is part of the natural bone remodeling process. However, in horses with navicular syndrome, excessive bone resorption can lead to pain and damage. By slowing this process, Osphos helps maintain healthier bone density, reduces inflammation, and alleviates discomfort in horses.

Uses of Osphos 51 Mg/Ml Solution For Injection:

Osphos is specifically indicated for the treatment of clinical signs associated with navicular syndrome in horses. This condition often leads to chronic pain and lameness, especially in the forelimbs. By managing the underlying bone resorption, Osphos provides long-term relief from pain and helps improve the horse’s performance and quality of life.

Key Benefits:

  • Reduces Pain:
    By inhibiting bone resorption, Osphos decreases inflammation and pain associated with navicular syndrome, leading to improved comfort and mobility.
  • Improves Mobility and Performance:
    Horses suffering from navicular syndrome often exhibit lameness and reduced performance. Treatment with Osphos can help restore normal movement and enhance the horse’s ability to perform.
  • Non-Surgical Treatment Option:
    Osphos offers an alternative to surgical treatments for navicular syndrome, providing a less invasive approach to managing the condition.

Administration and Dosage:

Osphos is administered as an intramuscular injection, with the recommend dosage being 1.8 mg/kg of body weight, which typically corresponds to 3 mL per 100 kg (220 lbs) of body weight. The total dose is divided into three injection sites for better absorption and effectiveness. Osphos should only be administered by a licensed veterinarian.

The effect of Osphos is generally seen within 2 months of treatment, with many horses showing significant improvements in pain levels and mobility. Depending on the response to treatment, the veterinarian may recommend repeat doses after a certain period.

Side Effects:

Although Osphos is generally well-tolerate, some horses may experience side effects, including:

  • Transient discomfort at the injection site.
  • Mild colic-like symptoms shortly after injection, which usually resolve without intervention.
  • Increased urination or drinking, although these effects are temporary.

In rare cases, more severe reactions such as allergic responses or prolonged colic symptoms may occur. If any adverse effects are observe, it is essential to contact a veterinarian immediately.

Precautions:
  • Osphos should not be use in horses with known hypersensitivity to clodronate disodium or other bisphosphonates.
  • It is not recommend for use in horses intended for human consumption.
  • Caution should be exercise in horses with pre-existing kidney issues, as bisphosphonates can affect renal function.
  • Pregnant or lactating mares should only be treat with Osphos under strict veterinary supervision, as the effects on fetal development are not fully understood.
Conclusion:

Osphos 51 mg/mL Solution for Injection is a highly effective treatment for horses suffering from navicular syndrome, providing long-lasting relief from pain and improving mobility. By targeting bone resorption, Osphos offers a non-invasive solution that helps horses regain their performance and quality of life. As with any medication, it is essential to administer Osphos under veterinary guidance, ensuring the correct dosage and monitoring for any potential side effects.

Reviews

There are no reviews yet.

Be the first to review “Osphos 51 Mg/Ml Solution For Injection”

Your email address will not be published. Required fields are marked *

Shopping Cart